Interference of plasma biotin in competitive immunoassay method:

Used to assay small targeted molecules, this method may display falsely high values, which may lead to misdiagnose a non-affected patient or to wrongly eliminate a diagnosis in an affected patient.

Please note that the information you will find in this website is for healthcare professionals who take care of patients treated with MD1003 / Qizenday®.

If you are a patient, this website contains important information for any healthcare professionals you may consult. Some laboratory tests may potentially be affected by using this medicine, including some that may be used in emergency situation. Therefore, you must always carry the card provided with the MD1003 / Qizenday leaflet and show it to any healthcare professional you see.

UDI: COM-010-002
Last update:04/05/2018